David A. Boothman, Ph.D.
Associate Director of Translational Research
David A. Boothman, Ph.D., is the inaugural Sid and Lois Eskenazi Professor of Oncology and professor of biochemistry and molecular biology at IU School of Medicine. He serves as associate director of translational research at the IU Simon Cancer Center, in which he is responsible for enhancing the cancer center's biomarker and therapeutic research, overseeing the translational cores, and serving as a liaison to the chemical biology pillar of the Precision Health Initiative.
Dr. Boothman is also a co-director of the Experimental and Developmental Therapeutics (EDT) research program at the IU Simon Cancer Center.
He is an internationally respected investigator who has focused on the mechanisms and exploitation of cell stress responses in cancer versus normal cells, and his work is supported by four current NIH/NCI awards.
Previously, Dr. Boothman held faculty and leadership positions at the Simmons Comprehensive Cancer Center/University of Texas Southwestern Medical Center in Dallas, Case Western Reserve University/Case Comprehensive Cancer Center, the University of Wisconsin-Madison, and the University of Michigan.
He earned a bachelor’s degree in microbiology from the University of Michigan and a doctorate in microbiology and immunology from the University of Miami. He completed a postdoctoral research fellowship at Dana-Farber Cancer Institute.
He is a member of the American Society for Microbiology, the American Association for Cancer Research, and the American Association for the Advancement of Science among others. Dr. Boothman is the elective representative for the Federation of American Societies for Experimental Biology for the Society of Experimental Biology (SEBM) and is currently president-elect of SEBM.